The Future of Ibuprofen API | Market Challenges & Opportunities

According to FutureWise analysis the market for Ibuprofen API in 2023 was US$ 7.5 billion, and is expected to reach US$ 9.5 billion by 2031 at a CAGR of 3.5%.

Ibuprofen is a white crystalline powder, with the chemical name 2-(4-isobutylphenyl) propionic acid and a molecular formula of C13H18O2. As the Active Pharmaceutical Ingredient (API) in ibuprofen, it is used to create various forms of the medication, including tablets, capsules, and syrups. This non-steroidal anti-inflammatory drug (NSAID) is effective for relieving pain, reducing fever, and decreasing inflammation. 

Ibuprofen works by inhibiting the production of prostaglandins, which are chemical messengers responsible for causing pain, fever, and inflammation in the body. By lowering the levels of these chemicals, ibuprofen can help alleviate pain and reduce inflammation. It is available in both prescription and over-the-counter forms and is commonly used to treat a variety of conditions, including headaches, menstrual cramps, toothaches, arthritis, and fever.

However, ibuprofen should be used with caution due to potential side effects, which can include stomach upset, gastrointestinal bleeding, and kidney damage. It is typically taken orally, either as tablets, capsules, or liquid suspensions. Ibuprofen is rapidly absorbed in the gastrointestinal tract, reaching peak plasma concentrations within 1-2 hours after ingestion. It has a half-life of approximately 2-4 hours and is metabolized by the liver.

Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=8924%20&type=requestsample

Ibuprofen API Market Segmentation:

By Product

• Rx
• OTC

By Application

• Headache
• Arthritis
• Others

By End User

• CROs and CMOs
• Biopharmaceutical and Pharmaceutical Companies
• Others

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Ibuprofen API Market:

• BASF SE
• Biocause Inc
• IOL Chemicals and Pharmaceuticals Limited
• SI Group, Inc
• Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd
• Solara Active Pharma Sciences Limited.

Buy Now the Latest Version of this Report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=8924&license=multi

**Objectives of this Study: **

1. To provide a comprehensive analysis of the Ibuprofen API Market By Product, By Application, By End User and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com